SeenewsSeenews
Search
Seenews
AlertsSeenewsSeenews
Searchclose
TOPICS
arrow
COUNTRIES
arrow
INDUSTRY
arrow
Economy
arrow
Browse Economy
Mix and match your focus countries with our advanced search
Latest in Economy
Investments
arrow
Browse Investments
Mix and match your focus countries with our advanced search
Deals
arrow
Browse Deals
Mix and match your focus countries with our advanced search
SEE TOP 100
arrow
Browse SEE TOP 100
Tech
arrow
Browse Tech
Mix and match your focus countries with our advanced search
Green
arrow
Browse Green
Mix and match your focus countries with our advanced search
0/5
You have 5 free articles left this month
You have 0/5 free articles
Get your free Basic subscription now and gain instant access to more
SIGN UP
arrow
LOGIN
arrow

Bulgaria's Sopharma sales up 3% y/y in Jan-April

May 21, 2024, 4:32:37 PMArticle by Mihaela Miteva
share
May 21 (SeeNews) - Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] said on Tuesday that its sales revenue rose by 3% on the year in the first four months of 2024 on the back of higher domestic sales.

Bulgaria's Sopharma sales up 3% y/y in Jan-April
Photo: Sopharma Business Towers

Revenue from sales on the domestic market grew by 11% year-on-year in January-April, whereas export sales went down 2%, Sopharma said in a bourse filing.

In April alone, Sopharma posted a 58% annual surge in sales revenue. The company's export sales soared by 60% on the year, while domestic sales jumped 55%.

As of 1530 CEST on Tuesday, shares in Sopharma traded flat at 6.12 levs ($3.40/3.13 euro) on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.